SEC Form 4 · accession 0001437749-18-018242
ZEVRA THERAPEUTICS, INC. · ZVRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gordon K Johnson
Officer — Chief Business Officer
Period of report
Oct 10, 2018
Accepted (ET)
Oct 12, 2018 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 10, 2018 | P | 2,000 | $2.60 | A | 8,000 | D | |
| Common Stock | Oct 10, 2018 | P | 1,000 | $2.6466 | A | 9,000 | D | |
| Common Stock | Oct 12, 2018 | P | 1,000 | $2.61 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.